Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that its presentation at the Credit Suisse 2013 Healthcare Conference, originally scheduled for November 13, 2013, has been rescheduled to November 12, 2013, at 8:00 a.m. MT (10:00 a.m. ET). A live audio webcast of Infinity’s presentations at the Credit Suisse conference will be accessible from the “Investors/Media” section of the company’s website, www.infi.com, and a replay will be available for 30 days following each event. About Infinity Pharmaceuticals, Inc. Infinity is an innovative biopharmaceutical company dedicated to discovering, developing and delivering best-in-class medicines to people with difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. For more information on Infinity, please refer to the company’s website at www.infi.com.